Verseau Therapeutics has a total of 75 patents globally, out of which none have been granted. Of these 75 patents, more than 90% patents are active. Europe (EPO) is where Verseau Therapeutics has filed the maximum number of patents. Parallelly, the United States seems to be the main focused R&D center of Verseau Therapeutics and is also the origin country of the firm.
Verseau Therapeutics was founded in the year 2017 by Daniel Anderson, Igor Feldman, Robert Langer and Tatiana Novobrantseva. The company develops a class of therapeutics, macrophage checkpoint modulators, to benefit patients with cancer, immune and inflammatory diseases.
Do read about some of the most popular patents of Verseau Therapeutics which have been covered by us in this article and also you can find Verseau Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Verseau Therapeutics patent portfolio.
How many patents does Verseau Therapeutics have?
Verseau Therapeutics has a total of 75 patents globally. These patents belong to 7 unique patent families. Out of 75 patents, 68 patents are active.
How Many Patents did Verseau Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
How many Verseau Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Verseau Therapeutics File in Different Countries?
Where are Research Centres of Verseau Therapeutics Patents Located?
The R&D Centre of patents filed by Verseau Therapeutics is in the US.
Most Cited Verseau Therapeutics Patent
US20210189342A1 is the most popular patent in the Verseau Therapeutics portfolio. It has received 5 citations so far from companies like Saudi Arabian Oil Company.
What are Verseau Therapeutics’ key innovation segments?
What Technologies are Covered by Verseau Therapeutics?
The chart below distributes patents filed by Verseau Therapeutics